Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib
Clinical trial NCT01844583 · COMPLETED
Trial details
- NCT number
- NCT01844583
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-25
- Primary completion
- 2014-08-04
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.